Joleen M Hubbard

14PUBLICATIONS
79CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer geneticsMolecular targetsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Nov 23, 2024
Trilaciclib prior to FOLFOXIRI/bevacizumab for patients with untreated metastatic colorectal cancer: phase 3 PRESERVE 1 trial.

Heinz-Josef Lenz, Tianshu Liu, Emerson Y Chen

|Oct 30, 2024
Onvansertib in Combination With Chemotherapy and Bevacizumab in Second-Line Treatment of KRAS-Mutant Metastatic Colorectal Cancer: A Single-Arm, Phase II Trial.

Daniel H Ahn, Maya Ridinger, Timothy L Cannon

|Jun 07, 2024
When Bad News Comes Through the Portal: Strengthening Trust and Guiding Patients When They Receive Bad Results Before Their Clinicians.

Liz Salmi, Joleen Hubbard, Daniel C McFarland

|May 25, 2024
Updates on the Management of Colorectal Cancer in Older Adults.

Conor D J O'Donnell, Joleen Hubbard, Zhaohui Jin

|Jan 18, 2024
Tumor-Informed Circulating Tumor DNA for Minimal Residual Disease Detection in the Management of Colorectal Cancer.

Oluwadunni E Emiloju, Michael Storandt, Tyler Zemla

|Aug 26, 2023
Evaluation of Intratumoral Response Heterogeneity in Metastatic Colorectal Cancer and Its Impact on Patient Overall Survival: Findings from 10,551 Patients in the ARCAD Database.

Fang-Shu Ou, Daniel H Ahn, Jesse G Dixon

Pageof 3

Frequent Collaborators

6 joint publications

Zhaohui Jin

3 joint publications

Robert R McWilliams

2 joint publications

Fang-Shu Ou

2 joint publications

Amit Mahipal